NEWARK, Calif., Feb. 8, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company’s programs and operations at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference to be held February 13-14 in New York City. Mr. McGlynn is scheduled to speak at 11:00 a.m. Eastern Time on Tuesday, February 14.
